|
Trial of VLTS-589 in Subjects with Intermittent Claudication Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Trial of VLTS-589 in Subjects with Intermittent Claudication conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Trial of VLTS-589 in Subjects with Intermittent Claudication Clinical research trials and Trial of VLTS-589 in Subjects with Intermittent Claudication health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Trial of VLTS-589 in Subjects with Intermittent Claudication. Trial of VLTS-589 in Subjects with Intermittent Claudication Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Trial of VLTS-589 in Subjects with Intermittent Claudication clinical trial. Human subjects often get the best healthcare possible for their Trial of VLTS-589 in Subjects with Intermittent Claudication condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Trial of VLTS-589 in Subjects with Intermittent Claudication  Trial of VLTS-589 in Subjects with Intermittent Claudication
Trial of VLTS-589 in Subjects with Intermittent Claudication
For Condition: Peripheral Vascular Disease,Intermittent Claudication
Status: Recruiting
Sponsor(s): Valentis ,
Synopsis: The purpose of this study is to evaluate the safety and tolerability of VLTS-589 compared with placebo, administered bilaterally to the lower extremities, in subjects with intermittent claudication and to determine the effect of VLTS-589 in peak walking time (PWT) for subjects receiving VLTS-589 compared with subjects receiving placebo.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 40 Years/80 Years
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Men or women between 40 and 80 years of age, - Must give informed consent, - Current medical history of peripheral arterial disease, which includes the following symptoms: leg pain, leg discomfort or leg weakness Exclusion criteria: - Ulcers or gangrene, - History of cancer (except skin cancer) within the past 5 years, - Participation in another clinical trial within 30 days of enrollment in this trial, - Unwillingness or inability to comply with all study requirements
Total Enrollment: 100
Location and Contact Information:
Daniel Gottleib, MD *Recruiting*
Seattle, Washington, 98166
United States
Recruiting
Arizona Heart Institute *Recruiting*
Phoenix, Arizona, 85016
United States
Recruiting
The Care Group *Recruiting*
Indianapolis, Indiana, 46260
United States
Recruiting
St. Vincent's Hospital *Recruiting*
New York City, New York, 10011
United States
Recruiting
Prairie Heart Institution at St. John's Hospital *Recruiting*
Springfield, Illinois, 62701
United States
Recruiting
Jacksonville Heart Center *Recruiting*
Jacksonville, Florida, 32207
United States
Recruiting
New Orleans Center for Clinical Research *Recruiting*
New Orleans, Louisiana, 70119
United States
Recruiting
Rush Presbyterian St. Luke's Medical Center *Recruiting*
Chicago, Illinois, 60612
United States
Recruiting
Dartmouth-Hitchcock Medical Center *Recruiting*
Lebanon, New Hampshire, 03756
United States
Recruiting
Duke Clinical Research Institute *Recruiting*
Durham, North Carolina, 27715
United States
Recruiting
University of Oklahoma Health Science Center *Recruiting*
Oklahoma City, Oklahoma, 73104
United States
Recruiting
Androscoggin Cardiology Associates *Recruiting*
Auburn, Maine, 04210
United States
Recruiting
Minneapolis Heart Institution Foundation *Recruiting*
Minneapolis, Minnesota, 55407
United States
Recruiting
University of Michigan Health Systems *Recruiting*
Ann Arbor, Michigan, 48109
United States
Recruiting
The Methodist Hospital *Recruiting*
Houston, Texas, 77030
United States
Recruiting
American Cardiovascular Research Institute *Recruiting*
Atlanta, Georgia, 30342
United States
Recruiting
Heart Specialists of Sarasota Clinical Research Center *Recruiting*
Sarasota, Florida, 34239
United States
Recruiting
Vanderbilt University Medical Center *Recruiting*
Nashville, Tennessee, 37232
United States
Recruiting
Access Clinical Trials-Cardiovascular Research *Recruiting*
Beverly Hills, California, 90210
United States
Recruiting
Cardiology Pc *Recruiting*
Birmingham, Alabama, 35211
United States
Recruiting
Additional Information:
Study ID Numbers: VLTS-589-121;
Study Start Date: June 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00068133
Other Peripheral Vascular Disease Studies:
1. Extract of Ginkgo Biloba (EGB 761) and Vascular Function
2. Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty
3. A safety and efficacy study of HGF via plasmid vector to improve perfusion in critical limb ischemia.
4. Trial of VLTS-589 in Subjects with Intermittent Claudication
5. Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
Related Studies:
Other Peripheral Vascular Disease Clinical Trials
Other Tennessee Clinical Trials
Other Nashville Clinical Trials
Trial of VLTS-589 in Subjects with Intermittent Claudication
|
|
|
|
|
|
|
|
